THEORETICAL STUDIES ON STRUCTURE-DIRECTING INTERACTIONS OF DIPHENYL N-(2-PYRAZINYL CARBONYL) PHOSPHORAMIDATE

Journal of Structural Chemistry - Herein, we report the strength of structure-directing interactions in the crystal packing of diphenyl N-(2-pyrazinyl carbonyl) phosphoramidate (1) through...     

Two minor phytoecdysteroids of the plant Silene viridiflora

Chemical investigations of Silene viridiflora (L.) yielded a new ecdysteroid, 20-hydroxyecdysone 20,22-monoacetonide-25-acetate (1), and a known ecdysteroid, 2-deoxypolypodine B-3-beta-D-glucoside (2). The elucidation of the chemical structures was established by 1D and 2D NMR experiments.     

Validation of the Antioxidant and Enzyme Inhibitory Potential of Selected Triterpenes Using In Vitro and In Silico Studies,and the Evaluation of Their ADMET Properties

The antioxidant and enzyme inhibitory potential of fifteen cycloartane-type triterpenes’ potentials were investigated using different assays. In the phosphomolybdenum method, cycloalpioside D (6) (4.05 mmol TEs/g) showed the highest activity. In 1,1-diphenyl-2-picrylhydrazyl (DPPH*) radical and 2,2′-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid (ABTS) cation radical scavenging assays, cycloorbicoside A-7-monoacetate (2) (5.03 mg TE/g) and cycloorbicoside B (10) (10.60 mg TE/g) displayed the highest activities, respectively. Oleanolic acid (14) (51.45 mg TE/g) and 3-O-β-d-xylopyranoside-(23R,24S)-16β,23;16α,24-diepoxycycloart-25(26)-en-3β,7β-diol 7-monoacetate (4) (13.25 mg TE/g) revealed the highest reducing power in cupric ion-reducing activity (CUPRAC) and ferric-reducing antioxidant power (FRAP) assays, respectively. In metal-chelating activity on ferrous ions, compound 2 displayed the highest activity estimated by 41.00 mg EDTAE/g (EDTA equivalents/g). The tested triterpenes showed promising AChE and BChE inhibitory potential with 3-O-β-d-xylopyranoside-(23R,24S)-16β,23;16α,24-diepoxycycloart-25(26)-en-3β,7β-diol 2′,3′,4′,7-tetraacetate (3), exhibiting the highest inhibitory activity as estimated from 5.64 and 5.19 mg GALAE/g (galantamine equivalent/g), respectively. Compound 2 displayed the most potent tyrosinase inhibitory activity (113.24 mg KAE/g (mg kojic acid equivalent/g)). Regarding α-amylase and α-glucosidase inhibition, 3-O-β-d-xylopyranoside-(23R,24S)-16β,23;16α,24-diepoxycycloart-25(26)-en-3β,7β-diol (5) (0.55 mmol ACAE/g) and compound 3 (25.18 mmol ACAE/g) exerted the highest activities, respectively. In silico studies focused on compounds 2, 6, and 7 as inhibitors of tyrosinase revealed that compound 2 displayed a good ranking score (−7.069 kcal/mole) and also that the ΔG free-binding energy was the highest among the three selected compounds. From the ADMET/TOPKAT prediction, it can be concluded that compounds 4 and 5 displayed the best pharmacokinetic and pharmacodynamic behavior, with considerable activity in most of the examined assays.     

N‐phosphinyl ureas: Synthesis,characterization, X‐ray structure,and in vitro evaluation of antitumor activity

A new series of N‐phosphinylureas 5b, 6a–7c was synthesized and characterized by ¹H, ¹³C, ³¹P NMR, IR, and elemental analysis. The three‐dimensional structure of 5b has been determined by X‐ray crystallography. The crystal structure revealed the existence of four independent molecules. All structures form two chains with different arrangements and connect to each other via hydrogen bonds to produce two‐dimensional polymeric chains. The cytotoxicity of cyclophosphamide (a standard antitumor compound) and its nine analogues with formula R¹C₆H₄ NHC(O)NHP(O)XCH₂C(R²)₂ CH₂Y(X = Y = NH, R² = CH₃, R¹ = H ( 5a ), CH₃ ( 5b ), NO₂ ( 5c ), X = O, Y = NH, R² = H, R¹ = H ( 6a , CH₃ ( 6b ), NO₂ ( 6c ), and X = Y = O, R² = CH₃, R¹ = H ( 7a ), CH₃ ( 7b ), NO₂ ( 7c )) as well as phenyl urea were evaluated in vitro against three human tumor cell lines K562, MDA‐MB‐231, and HepG2. The results showed that most of the compounds have significant activity against the selected cell lines. Also, HepG2 cells were more sensitive to all the tested compounds than other cell lines. © 2011 Wiley Periodicals, Inc. Heteroatom Chem 23:74–83, 2012; View this article online at wileyonlinelibrary.com . DOI 10.1002/hc.20754     

Nano- and micro-structure tin (IV) complexes bearing 4-pyridinecarbacylamidophosphate: Sonochemical synthesis,crystal structure,anti-cholinesterase activity,and docking studies

Two di- and triorganotin (IV) complexes, Sn (CH₃)₂Cl₂(4-PCAPh)₂ ( C ₁ ) and Sn(C₆H₅)₃Cl(4-PCAPh) ( C ₂ ); {4-PCAPh = 4-NC₅H₄C(O)NHP(O)(C₆H₁₂N)₂}, have been synthesized and characterized by elemental analysis, ¹H, ¹³C, ³¹P NMR and IR spectroscopy. The crystal structure of C ₁ has been confirmed by X-ray crystallography, which reveals an octahedral geometry surrounding Sn (IV). Both ligands function in an all-trans conformation, with an N-ligated mode for 4-PCAPh. Also, the complexes were prepared at nano- ( Ć ₁ ) and micro-size ( Ć ₂ ) by the sonochemical process. The role of reaction solvent and the concentration of initial reactants on the size and morphology of particles were studied and the products were characterized by X-ray powder diffraction (XRPD) and scanning electron microscopy (SEM). The activities and mechanism of complexes C ₁ , C ₂ , Ć ₁ , Ć ₂ and their corresponding ligand ( L ) on cholinesterase (ChE) were evaluated using a modified Ellman's method and Lineweaver-Burk plots. Nanosheet Ć ₁ showed the best activity against AChE and BChE with the IC₅₀ values being 73.08 ± 0.12 μM and 122.48 ± 0.69 μM, respectively, and the mixed-type mechanism. Molecular modeling simulation revealed the binding interaction template for Sn (CH₃)₂Cl₂(4-PCAPh)₂ with the ChE.     

Synthesis,structural characterization,density functional theory calculations and biological evaluation of a new organotin(IV) complex containing N‐isonicotinyl‐N',N″‐diaryl phosphorictriamide as N‐donor ligand

A new diorganotin(IV) complex with the formula SnCl₂(CH₃)₂L₂ ( C_1a ), L = 4‐NC₅H₄CONHPO(NCH₃CH₂C₆H₅)₂, was synthesized and characterized using ¹H NMR, ¹³C NMR, ³¹P NMR, ¹¹⁹Sn NMR and infrared spectroscopies. The molecular structure of C_1a was determined using X‐ray crystallography, revealing that C_1a contains hexa‐coordinated Sn(IV) centres with trans‐configuration of donor atoms around them. Each Sn(IV) atom is positioned in the centre of inversion of an octahedron. C_1a forms one‐dimensional chains via two equal intermolecular P?O…H? N hydrogen bonds. These hydrogen bonds produce centrosymmetric rings as a supramolecular hydrogen‐bonded pattern. In order to compare the relative stability of C_1a (with N‐ligated configuration) and its possible O‐ligated isomer, C_1b , density functional theory calculations were performed, the results showing a preference of C_1a over C_1b from an energy point of view. Also, natural bond orbital analysis was carried out to obtain detailed information on the electronic features of the optimized structures. The theoretical results show that intermolecular hydrogen bonding in the crystal structure has a significant role in the stabilization of C_1a , and Sn(IV) interacts more strongly with the N_py atom than the P?O functional group. Furthermore, the free ligand and its complex were tested against three human cancer cell lines, i.e. human cervical carcinoma (HeLa), human prostate cancer (PC‐3) and human breast adenocarcinoma cancer (MCF‐7). C_1a displays moderate to good cytotoxicity towards all three cancer cell lines. Moreover, antibacterial tests were carried out using the disc‐diffusion method, in which C_1a shows high activity against selected Gram‐negative and Gram‐positive bacteria. Copyright © 2015 John Wiley & Sons, Ltd.     

Sugar Containing Compounds and Biological Activities of Lagochilus setulosus

Phytochemical investigation of the methanolic extract obtained from the aerial parts of Lagochilus setulosus (Lamiaceae) afforded the new compound 1-methoxy-3-O-β-glucopyranosyl-α-l-oliose (1) together with five known glycosides, namely sitosterol-3-O-β-glucoside (2), stigmasterol-3-O-β-glucoside (3), pinitol (4), 6β-hydroxyl-7-epi-loganin (5), and chlorotuberoside (6). The structures of these compounds were elucidated by extensive spectroscopic analyses, especially HR-MS, 1D and 2D NMR spectroscopy. The in vitro cytotoxic activity of the methanolic extract and the isolated compounds was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and crystal violet (CV) staining assays. In addition, the antifungal activities of the components were evaluated against Botrytis cinerea, Septoria tritici, and Phytophthora infestans. The anthelmintic potential was determined against Caenorhabditis elegans nematodes. Neither the extract nor the isolated compounds showed promising activity in all the bioassays.     

Phosphodiesterase-I inhibitor quinovic acid glycosides from Bridelia ndellensis

Quinovic acid-3-O-alpha-L-rhamnopyranoside (1), quinovic acid-3-O-beta-D-fucopyranoside (2), quinovic acid-3-O-beta-D-glucopyranosyl (1 --> 4)-beta-D-fucopyranoside (3), methyl gallate (4) and ethyl gallate (5) were isolated from the ethyl acetate extract of Bridelia ndellensis barks by fractionation. Compounds 1-3 showed significant inhibitory activity against snake venom phosphodiesterase-I.     

Revisiting diterpene lactones of Suregada multiflora

Phytochemical investigations on the organic extracts of the leaves of Suregada multiflora have led to the isolation of ten tetracyclic diterpene lactones 1-10, members of a rare class of abiatene diterpene lactones. Compounds 1-5 were found to be new. The structures of gelomulides F (11), D (12) and E (13) were revised on the basis of 2D NMR and X-ray diffraction evidences. Compounds 1 and 2 contain an epoxy linkage between C-8 and C-14, whereas compounds 3-5 were identified as 8,14-dihydroxy analogues of diterpene lactones. The stereochemical assignments in new compound 1 are based on X-ray diffraction analysis. Compounds 6 and 7 were identified as the known gelomulides A, G. The structures of compounds 7-9 were unambiguously confirmed by X-ray diffraction analyses.